1. Zhang, Xiaoyan, Yang, Weili, Wang, Junpei, Guan, Youfei, Yang, Jichun. 2017. FAM3 gene family: A promising therapeutical target for NAFLD and type 2 diabetes. In Metabolism: clinical and experimental, 81, 71-82. doi:10.1016/j.metabol.2017.12.001. https://pubmed.ncbi.nlm.nih.gov/29221790/
2. Hu, Cheng-Qing, Hou, Tao, Xiang, Rui, Chi, Yu-Jing, Yang, Ji-Chun. 2024. PANX1-mediated ATP release confers FAM3A's suppression effects on hepatic gluconeogenesis and lipogenesis. In Military Medical Research, 11, 41. doi:10.1186/s40779-024-00543-6. https://pubmed.ncbi.nlm.nih.gov/38937853/
3. Yang, Weili, Chi, Yujing, Meng, Yuhong, Yan, Han, Yang, Jichun. 2020. FAM3A plays crucial roles in controlling PDX1 and insulin expressions in pancreatic beta cells. In FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 34, 3915-3931. doi:10.1096/fj.201902368RR. https://pubmed.ncbi.nlm.nih.gov/31944392/
4. Yan, Han, Meng, Yuhong, Li, Xin, Chi, Yujing, Yang, Jichun. 2022. FAM3A maintains metabolic homeostasis by interacting with F1-ATP synthase to regulate the activity and assembly of ATP synthase. In Metabolism: clinical and experimental, 139, 155372. doi:10.1016/j.metabol.2022.155372. https://pubmed.ncbi.nlm.nih.gov/36470472/
5. Xu, Tan, Wang, Jiaxing, Liu, Xiaoxiao, Yang, Jichun, Xu, Ming. 2023. FAM3A Deficiency - Induced Mitochondrial Dysfunction Underlies Post-Infarct Mortality and Heart Failure. In Journal of cardiovascular translational research, 17, 104-120. doi:10.1007/s12265-023-10382-w. https://pubmed.ncbi.nlm.nih.gov/37014466/
6. Xiang, Rui, Chen, Ji, Li, Shuangyue, Geng, Bin, Yang, Jichun. 2020. VSMC-Specific Deletion of FAM3A Attenuated Ang II-Promoted Hypertension and Cardiovascular Hypertrophy. In Circulation research, 126, 1746-1759. doi:10.1161/CIRCRESAHA.119.315558. https://pubmed.ncbi.nlm.nih.gov/32279581/
智鼠故事 
